| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |